Evaluation of Peptoid Mimics of Short, Lipophilic Peptide Antimicrobials

Evaluation of Peptoid Mimics of Short, Lipophilic Peptide Antimicrobials

Posted by Adam Awdish on

Single Donor Human Red Blood Cells from Innovative Research was used in the following study:

 

Evaluation of Peptoid Mimics of Short, Lipophilic Peptide Antimicrobials

R. Madison Green, Kevin L. Bicker

International Journal of Antimicrobial Agents
June 6, 2020

For patients recovering from surgery or dealing with weakened immune systems, nosocomial infections are a serious complication and may be fatal. These infections can be acquired through improper hygiene or inadequately cleaned surfaces. The ESKAPE pathogens, which include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp., are identified as the bacteria most often responsible for resistant, hospital-borne bacterial infections. Additionally, Candida albicans is the most common nosocomial fungal pathogen with high morbidity and mortality in immunocompromised patients. While not prevalent in hospital-borne infections, a second fungal pathogen, Cryptococcus neoformans, can result in deadly cryptococcosis or cryptococcal meningitis, especially in immunocompromised individuals.

Antimicrobial peptides (AMPs) are a part of the innate immune response of animals to microbial infection. Antimicrobial peptides are proving to be promising lead compounds for therapeutics. The major disadvantage of antimicrobial peptides, however, is their proteolytic instability in the body with half-lives averaging less than an hour.

Peptoids, or N-substituted glycines, have emerged as a promising field of peptidomimetics by retaining the beneficial properties of antimicrobial peptides while improving on their stability. This study evaluated peptoid derivatives of ultra-short lipophilic antimicrobial peptides, comparing their potency side-by-side against the most prevalent multidrug resistant bacteria (ESKAPE) and yeast pathogens (Candida albicans and Cryptococcus neoformans).

In general, peptides retained better antimicrobial activity than their peptoid counterparts, however, certain peptoids proved to be more effective than peptides against Gram-negative bacteria. All compounds tested were more potent against C. neoformans compared to C. albicans. Cytotoxicity analysis indicated that in general, peptoids were slightly less toxic than their peptide counterparts. Additionally, trypsin rapidly degraded one of the peptides evaluated while having no effect on comparable peptoids, demonstrating the proteolytic stability of peptoids. The study used Single Donor Human Red Blood Cells from Innovative Research, Inc. (Novi, MI).

 

Related products available from Innovative Research also include:

Pooled Human Red Blood Cells Lyophilized

Single Donor Human Red Blood Cells Washed

Single Donor Human Whole Blood

  • Tags: Human Blood Cells, Single Donor Human Red Blood Cells

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Plasma MMP-3: A Novel Biomarker Predicting ARDS Patient Outcomes
    In the quest to enhance patient care in critical conditions, the discovery of predictiv...
    Read the Article
    Top 5 Biologicals to Buy Right Now
    Innovative Research is excited to share our top 5 biological products that are making w...
    Read the Article
    Innovative Research’s Role in Developing a Zero-Gravity Versatile Sample Preparation Platform (VSPP)
    The realm of space exploration continually seeks innovations that can enhance the safet...
    Read the Article

    ← Older Post Newer Post →

    ×